Abstract
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1198-1200 |
| Number of pages | 3 |
| Journal | Kidney International |
| Volume | 70 |
| Issue number | 7 |
| DOIs | |
| State | Published - Oct 9 2006 |
Fingerprint
ASJC Scopus subject areas
- Nephrology
Cite this
Treatment of the primary hyperoxalurias : A new chapter. / Milliner, D.
In: Kidney International, Vol. 70, No. 7, 09.10.2006, p. 1198-1200.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of the primary hyperoxalurias
T2 - A new chapter
AU - Milliner, D.
PY - 2006/10/9
Y1 - 2006/10/9
N2 - Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
AB - Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
UR - http://www.scopus.com/inward/record.url?scp=33748923652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748923652&partnerID=8YFLogxK
U2 - 10.1038/sj.ki.5001821
DO - 10.1038/sj.ki.5001821
M3 - Article
C2 - 16988727
AN - SCOPUS:33748923652
VL - 70
SP - 1198
EP - 1200
JO - Kidney International
JF - Kidney International
SN - 0085-2538
IS - 7
ER -